Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Darren Cunningham
Preclinical Evaluation of a Novel Triple-Acting PIM/PI3K/mTOR Inhibitor, IBL-302, in Breast Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines Under Normoxic and Hypoxic Conditions
Breast Cancer: Basic and Clinical Research
Cancer Research
Oncology
PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Abrogating Phosphorylation of eIF4B Is Required for EGFR and mTOR Inhibitor Synergy in Triple-Negative Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget
Oncology
Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer
Oncogenesis
Cancer Research
Molecular Biology
Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
Journal of the American College of Surgeons
Surgery
Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Activity of Indatuximab Ravtansine Against Triple-Negative Breast Cancer in Preclinical Tumor Models
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Specific Apoptosis Induction by the Dual PI3K/mTor Inhibitor NVP-BEZ235 in HER2 Amplified and PIK3CA Mutant Breast Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
